Product Information

GLATIRAMER 20 MG/ML SYRINGE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $39.6680 per ML under NDC 00378696093. Its NADAC has been published 187 times since Aug 19, 2020.

FDA first approved this application on Oct 3, 2017. Its Orange Book therapeutic-equivalence code is AP.

GLATIRAMER 20 MG/ML SYRINGE

glatiramer acetate
$39.6680per ML

Strength

20 mg/mL

NDC

00378696093

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

10/21/2026

Active Ingredients

GLATIRAMER ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091646

FDA Approved

10/3/2017

TE Code

AP

On Market Since

10/4/2017

Price Statistics

The NADAC for GLATIRAMER 20 MG/ML SYRINGE has been published 187 times since Aug 19, 2020, and over the history we have for it it has declined 23.8%. The table below summarizes its recorded NADAC range and movement.

Current price$39.6680 per ML
All-time high$52.0697 (Aug 11, 2021)
All-time low$39.6680 (Oct 21, 2026)
52-week high$46.3979
52-week low$39.6680
Median price$48.4997
Average price$48.1963
Largest weekly change-8.0% (Aug 19, 2026)
Weeks tracked187
Tracking sinceAug 19, 2020

Price History

1W

0.0%

1M

-5.0%

3M

-7.1%

6M

-13.8%

1Y

-15.2%

3Y

-23.8%

5Y

-23.8%

All

-23.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glatiramer acetate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLATIRAMER 20 MG/ML SYRINGE?

The current National Average Drug Acquisition Cost (NADAC) for GLATIRAMER 20 MG/ML SYRINGE, manufactured by Mylan Pharmaceuticals Inc., is $39.6680 per ML (NDC 00378696093), effective Nov 11, 2026.

How has the price of GLATIRAMER 20 MG/ML SYRINGE changed over time?

Over the history we have for it, the NADAC for GLATIRAMER 20 MG/ML SYRINGE has declined 23.8%. It has been tracked across 187 weekly CMS publications since Aug 19, 2020.

What are the highest and lowest recorded NADAC prices for GLATIRAMER 20 MG/ML SYRINGE?

Since Aug 19, 2020, the NADAC for GLATIRAMER 20 MG/ML SYRINGE has ranged from a low of $39.6680 (Oct 21, 2026) to a high of $52.0697 (Aug 11, 2021), with a median of $48.4997 per ML.

Are there cheaper alternatives to GLATIRAMER 20 MG/ML SYRINGE?

No other NADAC-published product currently shares the active ingredient and strength of GLATIRAMER 20 MG/ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GLATIRAMER 20 MG/ML SYRINGE?

GLATIRAMER 20 MG/ML SYRINGE (NDC 00378696093) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.